J. Vuyk et al., Gender differences in the pharmacokinetics of propofol in elderly patientsduring and after continuous infusion, BR J ANAEST, 86(2), 2001, pp. 183-188
Citations number
14
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Differences in the pharmacokinetics of propofol between male and female pat
ients during and after continuous infusion have not been described in detai
l in patients aged 65 yr and older. To increase our insight, into the pharm
acokinetics of propofol in this patient population and to obtain pharmacoki
netic parameters applicable in target controlled infusion (TCl), the pharma
cokinetics of propofol during and after continuous infusion were studied in
31 ASA class 1 and 2 patients, aged 65-91 yr, scheduled for general surger
y. Patients received propofol 1.5 mg kg(-1) i.v. in 1 min followed by 7 mg
kg(-1) h(-1) until skin closure in the presence of a variable rate infusion
of alfentanil during oxygen-air ventilation. On the basis of arterial bloo
d samples that were taken up to 24 h post-infusion. the pharmacokinetics of
propofol were evaluated in a two-stage manner. Multiple linear regression
analysis was used to explore the effect of age, weight, gender and lean bod
y mass as covariates. Gender significantly affected the pharmacokinetics of
propofol. V-3 Cl-1 and Cl-2 were significantly different between male and
female patients, weight only affected Cl-1. The pharmacokinetic parameters
were: V-1=4.88 litre, V-2=24.50 litre, V-3 (litre)=115+147xgender (gender:
male=1, female=2), Cl-1 (litre min(-1))=-0.29+0.022x weight+0.22xgender, Cl
-2 (litre min(-1)=2.8-0.65xgender (male= 1, female=2), and Cl-3=0.788 litre
min(-1).